How do we define pneumonia?

Size: px
Start display at page:

Download "How do we define pneumonia?"

Transcription

1 Robert L. Keith MD FCCP Associate Professor of Medicine Division of Pulmonary Sciences & Critical Care Medicine Denver VA Medical Center University of Colorado Denver How do we define pneumonia? Fever Sputum production Radiographic infiltrate Dilemmas in CAP management Use of Immunomodulatory Agents Duration of Treatment Need for follow-up imaging Smoking cessation counseling at time of CAP Performance Measures for CAP management

2 Dilemma #1: Use of Immunomodulatory Agents 51 yo male presents with d of cough, SOB, fever, anorexia PMH: Htn, Gout, EtOH abuse PE: T=101.1, 115/72, 83% on RA Crackles in R mid lung WBC=13.7 Immunomodulatory Agents: Do they improve CAP outcome? Observation: Mortality from invasive pneumococcal pneumonia remains at 20% (2/3rds die within 1 week of admission) Inflammatory Events may be responsible for many of the poor outcomes in severe CAP Could immunomodulatory agents that suppress the immune response improve outcome?

3 Which agent improves CAP outcome: a. Macrolides b. Statins c. Steroids d. NSAIDs e. None of the above Immunomodulatory Agents 1. Macrolides: critical part of many treatment pathways. Concentrated in phagocytic cells and inhibit neutrophils and cytokine production 2. Statins: immunomodulatory and dampen the immune response. Meta-analysis 47% less mortality. Severe CAP & ARDS trials in progress 3. Steroids: have been studied. Multiple RCTs and no effect on mortality. Recent study showed 4d of dexamethasone decreased LoS by 1d. 4. NSAIDs: no evidence to support use. Overall, there may be a role for these in selected patients with severe CAP.

4 Dilemma #2: Duration of Treatment How long should patients be treated for CAP? Case: 57 yo male with malaise, dry cough, and altered mental status. PMH: Htn, gout, ESRD-on dialysis PE: confused male, T-101.7, 88/45, 85%-RA Pulm: crackles ant, upper R chest WBC: 12.8 Duration of Treatment How long should this patient be treated with antibiotics? days days 3. 7 days 4. 5 days after he is afebrile

5 Duration of Treatment for CAP Traditional treatment duration has been 10-14d 2 recent meta-analyses have concluded that short courses (<7d) are as effective as longer courses (FQ, azithro, or other abx) Evidence based treatment: should treat for a minimum of 5d if afebrile for 48h, no more than one CAPassociated sign of clinical instability Longer duration if initial treatment not active against identified pathogen or if complicated by extrapulmonary infection (meningitis, endocarditis, empyema) Still need to treat L. pneumophila for 14d CAP associated signs of clinical instability and CAP complications Dilemma #3: Follow-up Imaging Question: Should a CXR be repeated after documented pneumonia to show resolution? Case: 78 yo with persistent cough, productive of yellow sputum, and worsening SOB PE: 36.5, 126/75, 83% on RA Pulm: crackles in R base, soft exp wheeze Ext: no edema WBC: 7.1

6 Should CXR infiltrates be followed to resolution? (i.e. could I be missing a lung cancer?)

7 Follow-up Imaging Conclusions: Incidence of new lung cancer: 1.1% at 90d, 1.7% at 1 year and 2.3% at 5 years Characteristics independently associated with new lung cancer diagnosis: male sex, age>50, current smoking Bottom Line: Follow-up imaging (90d CXR) in subjects at increased risk of lung cancer (diff study in male veterans found 5 years incidence of 9.2%) Dilemma #4:Smoking Cessation Counseling when CAP is diagnosed This is a Joint Commission and CMMS performance measure in many systems to monitor the quality of care Case: 58 yo male presents with SOB, cough, fever and sputum production. He currently smokes 2ppd PE: T-100.8, 96/53, 93% on 2L O2 Pul: crackles in L upper Cor: tachy, no m/g/r Should this pt receive smoking cessation counseling?

8 Smoking Cessation Counseling Performance measure: Hospitalized CAP patients with a history of smoking within the last year, how many received advice or counseling 10 RCT (compared advice to no invervention) Conclusion: inpt cessation counseling w/o outpt follow-up did not improve quit rates (15.9% vs. 15.6%) RR 1.05, 95% CI Other CAP Performance Measures Which of the Following Measures have been shown to be effective with high quality evidence? 1. Pnemococcal Vaccination 2. Blood cultures 3. Antibiotics administration within 6 hours 4. Use of guideline compliant antibiotics 5. Influenza Vaccination

9 Pneumococcal Vaccination Performance Measure: Identify pts > 65yo hospitalized with CAP and vaccinate prior to discharge 15 RCTs Meta-analysis: Vaccination decreased incidence of pneumococcal pneumonia & invasive disease Quality of evidence: low Blood Cultures Performance Measure: Patients admitted or transferred to ICU w/in 24h of admission for CAP 2 retrospective cohort studies (compared those with cultures to those without) Negative blood cultures associated with improved survival and those with blood cultures drawn were more stable at 48h Quality of evidence: low Blood cx do help determine guidelines (community wide resistance patterns) Antibiotic within 6 hours Performance Measure: Proportion of adult CAP patients who receive first dose of antibiotics within 6h of hospital arrival Most prior studies examined a 4h timepoint Extrapolated data has shown abx within 6h associated with shorter hospital stay, and possibly decreased mortality Quality of evidence: low

10 Guideline-Compliant Antibiotics Performance Measure: Proportion of adult CAP patients who receive an initial antibiotic regimen c/w guidelines in first 24h of hosp. 2 retrospective and 6 observational studies Studies consistently show decreased mortality. Quality of evidence: moderate IDSA/ATS Guidelines:Outpatient Treatment Recommendations for Empiric Antibiotic Selection Group I No cardiopulmonary disease + no modifying factors Advanced-generation macrolide (azithromycin or clarithromycin), Moxifloxacin, or Doxycycline* Group II Cardiopulmonary disease +/- other modifying factors β-lactam + (macrolide or doxycycline*), or Respiratory fluoroquinolone ATS Guidelines: Hospitalized Patients Antibiotic Selection In-patients, non-icu: Respiratory FQ or β-lactam + macrolide ICU: No risks for Pseudomonas aeruginosa IV β-lactam +IV macrolide (azithromycin) or IV fluoroquinolone ICU: Risks for P aeruginosa Selected IV antipseudomonal β-lactam + IV antipseudomonal quinolone or Selected IV antipseudomonal β-lactam + IV aminoglycoside + IV macrolide or IV nonpseudomonal fluoroquinolone

11 Influenza Vaccination Performance Measure: the proportion of CAP patients (age >50) hospitalized October-March and vaccinated if necessary 26 RCTs Meta-analysis: Influenza vaccination decreases lab-confirmed cases of symptomatic influenza, and influenza-like illnesses Quality of evidence: high Other CAP Performance Measures Which of the Following Measures have been shown to be effective with high quality evidence? 1. Pnemococcal Vaccination 2. Blood cultures 3. Antibiotics administration within 6 hours 4. Use of guideline compliant antibiotics 5. Influenza Vaccination Maintaining Success for Tomorrow Know your community prevalence of atypical/resistant pathogens Know your patient host competence / co-morbidities. Up to 10% of patients may not respond. Know when to start appropriate antibiotic therapy and when to stop Advise patients to finish entire course of therapy Baquero F. J Chemother. 1999;11:35-43.

Pneumonia Community-Acquired Healthcare-Associated

Pneumonia Community-Acquired Healthcare-Associated Pneumonia Community-Acquired Healthcare-Associated Edwin Yu Clin Infect Dis 2007;44(S2):27-72 Am J Respir Crit Care Med 2005; 171:388-416 IDSA / ATS Guidelines Microbiology Principles and Practice of Infectious

More information

Antimicrobial Stewardship in Community Acquired Pneumonia

Antimicrobial Stewardship in Community Acquired Pneumonia Antimicrobial Stewardship in Community Acquired Pneumonia Medicine Review Course 2018 Dr Lee Tau Hong Consultant Department of Infectious Diseases National Centre for Infectious Diseases Scope 1. Diagnosis

More information

UPDATE IN HOSPITAL MEDICINE

UPDATE IN HOSPITAL MEDICINE UPDATE IN HOSPITAL MEDICINE FLORIDA CHAPTER ACP MEETING 2016 Himangi Kaushal, M.D., F.A.C.P. Program Director Memorial Healthcare System Internal Medicine Residency DISCLOSURES None OBJECTIVES Review some

More information

Bradley A. Sharpe, M.D. Associate Professor Medicine Department of Medicine UCSF

Bradley A. Sharpe, M.D. Associate Professor Medicine Department of Medicine UCSF Maximizing Care for Community- Acquired Pneumonia Bradley A. Sharpe, M.D. Associate Professor Medicine Department of Medicine UCSF sharpeb@medicine.ucsf.edu 1. In 1898, William Osler described community-acquired

More information

Charles Krasner, M.D. University of NV, Reno School of Medicine Sierra NV Veterans Affairs Medical Center

Charles Krasner, M.D. University of NV, Reno School of Medicine Sierra NV Veterans Affairs Medical Center Charles Krasner, M.D. University of NV, Reno School of Medicine Sierra NV Veterans Affairs Medical Center Kathy Peters is a 63 y.o. patient that presents to your urgent care office today with a history

More information

Pneumonia in the Hospitalized

Pneumonia in the Hospitalized Pneumonia in the Hospitalized Patient: Use of Steroids Nicolette Myers, MD Pulmonary/Sleep/Critical Care November 9, 2018 Park Nicollet Clinic Facts About Pneumonia CAP is the 8 th most common cause of

More information

Bradley A. Sharpe, M.D. Associate Professor Medicine Department of Medicine UCSF -- William Osler, M.D.

Bradley A. Sharpe, M.D. Associate Professor Medicine Department of Medicine UCSF -- William Osler, M.D. Bradley A. Sharpe, M.D. Associate Professor Medicine Department of Medicine UCSF sharpeb@medicine.ucsf.edu a. An ailment that often leads to suffocation and death. b. A friend of the aged. c. A common

More information

Community Acquired & Nosocomial Pneumonias

Community Acquired & Nosocomial Pneumonias Community Acquired & Nosocomial Pneumonias IDSA/ATS 2007 & 2016 Guidelines José Luis González, MD Clinical Assistant Professor of Medicine Outline Intro - Definitions & Diagnosing CAP treatment VAP & HAP

More information

CAP, HCAP, HAP, VAP. 1. In 1898, William Osler described community-acquired pneumonia as:

CAP, HCAP, HAP, VAP. 1. In 1898, William Osler described community-acquired pneumonia as: 1. In 1898, William Osler described community-acquired pneumonia as: Brad Sharpe, M.D. Professor of Clinical Medicine Department of Medicine UCSF sharpeb@medicine.ucsf.edu I have no relevant financial

More information

Guidelines. 14 Nov Marc Bonten

Guidelines. 14 Nov Marc Bonten Guidelines 14 Nov 2014 Marc Bonten Treatment of Community-Acquired Pneumonia SWAB/ NVALT guideline 2011, replaced SWAB guideline 2005 Empirical treatment must cover the most likely causative pathogen.

More information

Community Acquired Pneumonia: Measures to Improve Management and Healthcare Quality

Community Acquired Pneumonia: Measures to Improve Management and Healthcare Quality Community Acquired Pneumonia: Measures to Improve Management and Healthcare Quality Gonzalo Bearman MD, MPH Assistant Professor of Internal Medicine Divisions of Quality Health Care & Infectious Diseases

More information

Aspiration pneumonia in older people

Aspiration pneumonia in older people Aspiration pneumonia in older people Ayman Morish, M.D. Internal medicine, Critical care Medicine and Geriatrics Fellow. Contents Epidemiology Causes of aspiration pneumonia Issues of older age Management

More information

WORKSHOP. The Multiple Facets of CAP. Community acquired pneumonia (CAP) continues. Jennifer s Situation

WORKSHOP. The Multiple Facets of CAP. Community acquired pneumonia (CAP) continues. Jennifer s Situation Practical Pointers pointers For for Your your Practice practice The Multiple Facets of CAP Dr. George Fox, MD, MSc, FRCPC, FCCP Community acquired pneumonia (CAP) continues to be a significant health burden

More information

COPD: From Hospital to Home October 5, 2015 Derek Linderman, MD Associate Professor COPD Center Pulmonary Nodule Clinic

COPD: From Hospital to Home October 5, 2015 Derek Linderman, MD Associate Professor COPD Center Pulmonary Nodule Clinic COPD: From Hospital to Home October 5, 2015 Derek Linderman, MD Associate Professor COPD Center Pulmonary Nodule Clinic Learning Objectives Know the adverse effects of COPD exacerbations Know mainstays

More information

Community-acquired pneumonia in adults

Community-acquired pneumonia in adults Prim Care Clin Office Pract 30 (2003) 155 171 Community-acquired pneumonia in adults Julio A. Ramirez, MD a,b, * a Department of Medicine, University of Louisville School of Medicine, 512 S. Hancock Street,

More information

Deep discoveries: the ED. Brian H. Rowe, MD, MSc, CCFP(EM) Canada Research Chair in Emergency Airway Diseases Department of Emergency Medicine

Deep discoveries: the ED. Brian H. Rowe, MD, MSc, CCFP(EM) Canada Research Chair in Emergency Airway Diseases Department of Emergency Medicine Deep discoveries: Treating respiratory infections in the ED. Brian H. Rowe, MD, MSc, CCFP(EM) Canada Research Chair in Emergency Airway Diseases Department of Emergency Medicine University of Alberta Respiratory

More information

Brice Taylor Assistant Professor Division of Pulmonary and Critical Care Medicine

Brice Taylor Assistant Professor Division of Pulmonary and Critical Care Medicine Brice Taylor Assistant Professor Division of Pulmonary and Critical Care Medicine Discuss advances in predicting prognosis Understand dwhat we know (and don t know) about the Microbiology Recognize important

More information

Pneumonia (PN) Frequently Asked Questions (FAQs) 2Q09 and 3Q09. Adult Smoking History. Another Suspected Source of Infection

Pneumonia (PN) Frequently Asked Questions (FAQs) 2Q09 and 3Q09. Adult Smoking History. Another Suspected Source of Infection Pneumonia (PN) Frequently Asked Questions (FAQs) Adult Smoking History The nurse wrote patient smoker for 15 years but does not indicate when or if he quit. The physician in the H&P wrote "The patient

More information

COPD: A Renewed Focus. Disclosures

COPD: A Renewed Focus. Disclosures COPD: A Renewed Focus Heath Latham, MD Assistant Professor Division of Pulmonary and Critical Care Medicine Disclosures No Business Interests No Consulting No Speakers Bureau No Off Label Use to Discuss

More information

Michael S. Niederman, M.D. Clinical Director Pulmonary and Critical Care Medicine New York Presbyterian Hospital Weill Cornell Medical Center

Michael S. Niederman, M.D. Clinical Director Pulmonary and Critical Care Medicine New York Presbyterian Hospital Weill Cornell Medical Center CA-MRSA Pneumonia Michael S. Niederman, M.D. Clinical Director Pulmonary and Critical Care Medicine New York Presbyterian Hospital Weill Cornell Medical Center Professor of Clinical Medicine Weill Cornell

More information

The McMaster at night Pediatric Curriculum

The McMaster at night Pediatric Curriculum The McMaster at night Pediatric Curriculum Community Acquired Pneumonia Based on CPS Practice Point Pneumonia in healthy Canadian children and youth and the British Thoracic Society Guidelines on CAP Objectives

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients

More information

KAISER PERMANENTE OHIO COMMUNITY ACQUIRED PNEUMONIA

KAISER PERMANENTE OHIO COMMUNITY ACQUIRED PNEUMONIA KAISER PERMANENTE OHIO COMMUNITY ACQUIRED PNEUMONIA Methodology: Expert opinion Issue Date: 8-97 Champion: Pulmonary Medicine Most Recent Update: 6-08, 7-10, 7-12 Key Stakeholders: Pulmonary Medicine,

More information

Case Study #2. Case Study #1 cont 9/28/2011. CAPA 2011 Christy Wilson PA C. LH is 78 yowf with PMHx of metz breast CA presents

Case Study #2. Case Study #1 cont 9/28/2011. CAPA 2011 Christy Wilson PA C. LH is 78 yowf with PMHx of metz breast CA presents Case Study #1 CAPA 2011 Christy Wilson PA C 46 yo female presents with community acquired PNA (CAP). Her condition worsened and she was transferred to the ICU and placed on mechanical ventilation. Describe

More information

COPD Treatable. Preventable.

COPD Treatable. Preventable. My COPD Action Plan Patient s Copy (Patient s Name) Date Canadian Respiratory COPD Treatable. Preventable. This is to tell me how I will take care of myself when I have a COPD flare-up. My goals are My

More information

Community-Acquired Pneumonia OBSOLETE 2

Community-Acquired Pneumonia OBSOLETE 2 Community-Acquired Pneumonia OBSOLETE 2 Clinical practice guidelines serve as an educational reference, and do not supersede the clinical judgment of the treating physician with respect to appropriate

More information

Community-Acquired Pneumonia. Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital. Nothing to disclose.

Community-Acquired Pneumonia. Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital. Nothing to disclose. Community-Acquired Pneumonia Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital Nothing to disclose. Community-Acquired Pneumonia Talk will focus on adults Guideline

More information

Dr Conroy Wong. Professor Richard Beasley. Dr Sarah Mooney. Professor Innes Asher

Dr Conroy Wong. Professor Richard Beasley. Dr Sarah Mooney. Professor Innes Asher Professor Richard Beasley University of Otago Director Medical Research Institute of New Zealand Wellington Dr Sarah Mooney Physiotherapy Advanced Clinician Counties Manukau Health NZ Respiratory and Sleep

More information

Community Acquired Pneumonia. Abdullah Alharbi, MD, FCCP

Community Acquired Pneumonia. Abdullah Alharbi, MD, FCCP Community Acquired Pneumonia Abdullah Alharbi, MD, FCCP A 68 y/ male presented to the ED with SOB and productive coughing for 2 days. Reports poor oral intake since onset due to nausea and intermittent

More information

Avian Influenza A (H7N9): Clinical Management. KW Choi Associate Consultant IDCTC, HA/ ICB, CHP

Avian Influenza A (H7N9): Clinical Management. KW Choi Associate Consultant IDCTC, HA/ ICB, CHP Avian Influenza A (H7N9): Clinical Management KW Choi Associate Consultant IDCTC, HA/ ICB, CHP Initial symptoms: nonspecific, similar to most other causes of ILI, CAP High index of suspicion and alertness

More information

Getting Smart About: Upper Respiratory Infections

Getting Smart About: Upper Respiratory Infections Getting Smart About: Upper Respiratory Infections Daniel Z. Uslan, MD Assistant Clinical Professor Director, Antimicrobial Stewardship Program UCLA Health System Disclosures None relevant to the topic

More information

The IDSA/ATS consensus guidelines on the management of CAP in adults

The IDSA/ATS consensus guidelines on the management of CAP in adults The IDSA/ATS consensus guidelines on the management of CAP in adults F. Piffer F. Tardini R. Cosentini U.O. Medicina d'urgenza, Gruppo NIV, Fondazione Ospedale Maggiore Policlinico, Mangiagalli e Regina

More information

Community Acquired Pneumonia. Background & Rationale to North American Guidelines. Lionel Mandell MD FRCPC Brussels Belgium

Community Acquired Pneumonia. Background & Rationale to North American Guidelines. Lionel Mandell MD FRCPC Brussels Belgium Community Acquired Pneumonia Background & Rationale to North American Guidelines Lionel Mandell MD FRCPC Brussels Belgium Consider Impact of the disease Issues to reflect upon Impact of the Disease 3-4

More information

Pneumonia. Dr. Rami M Adil Al-Hayali Assistant professor in medicine

Pneumonia. Dr. Rami M Adil Al-Hayali Assistant professor in medicine Pneumonia Dr. Rami M Adil Al-Hayali Assistant professor in medicine Definition Pneumonia is an acute respiratory illness caused by an infection of the lung parenchyma, associated with recently developed

More information

Hospital-acquired Pneumonia

Hospital-acquired Pneumonia Hospital-acquired Pneumonia Hospital-acquired pneumonia (HAP) Pneumonia that occurs at least 2 days after hospital admission. The second most common and the leading cause of death due to hospital-acquired

More information

Disclosures. Case 1. Acute Bronchitis. Acute Bronchitis. Community-Acquired Pneumonia and other Respiratory Tract Infections. What do you recommend?

Disclosures. Case 1. Acute Bronchitis. Acute Bronchitis. Community-Acquired Pneumonia and other Respiratory Tract Infections. What do you recommend? Community-Acquired Pneumonia and other Respiratory Tract Infections none Disclosures Joel T. Katz, M.D. Associate Professor of Medicine Division of Infectious Diseases Brigham and Women s Hospital Case

More information

Pneumonia 2017 OMAR PIRZADA

Pneumonia 2017 OMAR PIRZADA Pneumonia 2017 OMAR PIRZADA Pneumonia Pneumonia is common 0.5-1% of adults per year, 5-12% presenting to GP with LRTi 22-42% will be admitted to hospital Symptoms and signs Case 1 26 year old man Sudden

More information

Pneumonia: The Forgotten Killer

Pneumonia: The Forgotten Killer Pneumonia: The Forgotten Killer David Glenn Weismiller, MD, ScM, FAAFP Department of Family and Community Medicine University of Nevada, Las Vegas School of Medicine Disclosure Statement It is the policy

More information

PULMONARY EMERGENCIES

PULMONARY EMERGENCIES EMERGENCIES I. Pneumonia A. Bacterial Pneumonia (most common cause of a focal infiltrate) 1. Epidemiology a. Accounts for up to 10% of hospital admissions in the U.S. b. Most pneumonias are the result

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Blum CA, Nigro N, Briel M, et al. Adjunct prednisone

More information

TB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012

TB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012 TB: Management in an era of multiple drug resistance Bob Belknap M.D. Denver Public Health November 2012 Objectives: 1. Explain the steps for diagnosing latent and active TB role of interferon-gamma release

More information

CLAIRE NOWLAN & SAM SEARLE. Pneumonia in the nursing home

CLAIRE NOWLAN & SAM SEARLE. Pneumonia in the nursing home CLAIRE NOWLAN & SAM SEARLE Pneumonia in the nursing home No disclosures or conflicts of interest PMHX: A. FIB. GERD MIXED DEMENTIA MMSE 16/30 HTN Mr. Hack 86 years old RAMIPRIL 4 MG OD PARIET 20MG OD DONEPEZIL

More information

Guidelines/Guidance/CAP/ Hospitalized Child. PHM Boot Camp 2014 Jay Tureen, MD June 19, 2014

Guidelines/Guidance/CAP/ Hospitalized Child. PHM Boot Camp 2014 Jay Tureen, MD June 19, 2014 Guidelines/Guidance/CAP/ Hospitalized Child PHM Boot Camp 2014 Jay Tureen, MD June 19, 2014 CAP in Children: Epi Greatest cause of death in children worldwide Estimated > 2 M deaths in children In developed

More information

Pediatric Infections: Treatment of Resistant Pathogens. Focus : MRSA and DRSP Infections, Including Pneumonia. Blaise L. Congeni M.D.

Pediatric Infections: Treatment of Resistant Pathogens. Focus : MRSA and DRSP Infections, Including Pneumonia. Blaise L. Congeni M.D. Pediatric Infections: Treatment of Resistant Pathogens Focus : MRSA and DRSP Infections, Including Pneumonia Blaise L. Congeni M.D. Patient 1-LP 8 yo with 8 days of fever and 6 days of cough. She had consistently

More information

Pneumonia Update Overview" Community-Acquired Pneumonia" Management of the Hospitalized Patient. Care of the Hospitalized Patient"

Pneumonia Update Overview Community-Acquired Pneumonia Management of the Hospitalized Patient. Care of the Hospitalized Patient Pneumonia Update 2010 Management of the Hospitalized Patient Scott A. Flanders, M.D." Professor of Medicine" Director, Hospitalist Program" University of Michigan" Overview" Community Acquired Pneumonia

More information

Sepsis new definitions of sepsis and septic shock and Novelities in sepsis treatment

Sepsis new definitions of sepsis and septic shock and Novelities in sepsis treatment Sepsis new definitions of sepsis and septic shock and Novelities in sepsis treatment What is sepsis? Life-threatening organ dysfunction caused by a dysregulated host response to infection A 1991 consensus

More information

Background. Background. Background 3/14/2014. Conflict of Interest Statement:

Background. Background. Background 3/14/2014. Conflict of Interest Statement: Platform Presentations Comparison of zolpidem to other drugs associated with falls in hospitalized patients Ed Rainville, MSPharm. Conflict of Interest Statement: The speaker has no conflict of interest

More information

TB and Comorbidities Adriana Vasquez, MD April 12, 2018

TB and Comorbidities Adriana Vasquez, MD April 12, 2018 TB and Comorbidities Adriana Vasquez, MD April 12, 2018 TB Nurse Case Management April 10 12, 2018 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Adriana Vasquez, MD has the following disclosures to make:

More information

Things your mother never told you about antibiotics, UTI s, and Pneumonia. Rob Kaplan, MD July 12 and 14, 2017

Things your mother never told you about antibiotics, UTI s, and Pneumonia. Rob Kaplan, MD July 12 and 14, 2017 Things your mother never told you about antibiotics, UTI s, and Pneumonia Rob Kaplan, MD July 12 and 14, 2017 Objectives After this talk participants will: Be able to articulate some of the principles

More information

What is sepsis? RECOGNITION. Sepsis I Know It When I See It 9/21/2017

What is sepsis? RECOGNITION. Sepsis I Know It When I See It 9/21/2017 Sepsis I Know It When I See It September 15, 2017 Matthew Exline, MD MPH Medical Director, Medical ICU What is sepsis? I shall not today attempt further to define the kinds of material [b]ut I know it

More information

Pleural Effusions. Kyle J Henry, MD Pulmonary/ CCM Fellow PGY4 (210) (602)

Pleural Effusions. Kyle J Henry, MD Pulmonary/ CCM Fellow PGY4 (210) (602) Pleural Effusions Kyle J Henry, MD Pulmonary/ CCM Fellow PGY4 (210) 275 8583 (602) 202 0351 None Disclosures Objectives Understand the presentation of a pleural effusion How to diagnose and treat Differentiate

More information

Case Report Form Anti-Influenza Therapy in Hospitalized patients with Community-Acquired Pneumonia January 2012

Case Report Form Anti-Influenza Therapy in Hospitalized patients with Community-Acquired Pneumonia January 2012 Case Report Form Anti-Influenza Therapy in Hospitalized patients with Community-Acquired Pneumonia January 2012 Principal Investigator: Hospital: Subject Name: Medical Record Number: Page 1 of 19 DEMOGRAPHICS

More information

Lecture Notes. Chapter 16: Bacterial Pneumonia

Lecture Notes. Chapter 16: Bacterial Pneumonia Lecture Notes Chapter 16: Bacterial Pneumonia Objectives Explain the epidemiology Identify the common causes Explain the pathological changes in the lung Identify clinical features Explain the treatment

More information

Best timing for surgical intervention of empyema. Supervisor: Intern:

Best timing for surgical intervention of empyema. Supervisor: Intern: Best timing for surgical intervention of empyema Supervisor: Intern: Brief history 56 y/o male, farmer With anesthesia medication at LMD Admission 30d 7d Dry cough Progressive productive cough with yellow

More information

COPD/Asthma. Prudence Twigg, AGNP

COPD/Asthma. Prudence Twigg, AGNP COPD/Asthma Prudence Twigg, AGNP COPD/Asthma Qualifying Diagnosis Known diagnosis of COPD/asthma or CXR showing COPD with hyperinflated lungs and no infiltrates + two or more: Wheezing, SOB, increased

More information

Pneumonia. Definition of pneumonia Infection of the lung parenchyma Usually bacterial

Pneumonia. Definition of pneumonia Infection of the lung parenchyma Usually bacterial Pneumonia Definition of pneumonia Infection of the lung parenchyma Usually bacterial Epidemiology of pneumonia Commonest infectious cause of death in the UK and USA Incidence - 5-11 per 1000 per year Worse

More information

62 year old man with a cough! Dr. Aflah Sadikeen Consultant Respiratory Physician Colombo

62 year old man with a cough! Dr. Aflah Sadikeen Consultant Respiratory Physician Colombo 62 year old man with a cough! Dr. Aflah Sadikeen Consultant Respiratory Physician Colombo History Mr.KS, a 62 year-old, has been feeling unwell - Worsening cough for the last 5 days - Feels out of breath

More information

To develop guidelines for the use of appropriate antibiotics for adult patients with CAP and guidance on IV to PO conversion.

To develop guidelines for the use of appropriate antibiotics for adult patients with CAP and guidance on IV to PO conversion. Page 1 of 5 TITLE: COMMUNITY-ACQUIRED PNEUMONIA (CAP) EMPIRIC MANAGEMENT OF ADULT PATIENTS AND IV TO PO CONVERSION GUIDELINES: These guidelines serve to aid clinicians in the diagnostic work-up, assessment

More information

Session: How to manage and prevent the different faces of pneumonia Severe CAP

Session: How to manage and prevent the different faces of pneumonia Severe CAP Athens 19, 20 November 2015 Garyfallia Poulakou Consultant, Infectious Diseases 4 th Department of Internal Medicine, Attikon University Hospital of Athens Session: How to manage and prevent the different

More information

Polmoniti: Steroidi sì, no, quando. Alfredo Chetta Clinica Pneumologica Università degli Studi di Parma

Polmoniti: Steroidi sì, no, quando. Alfredo Chetta Clinica Pneumologica Università degli Studi di Parma Polmoniti: Steroidi sì, no, quando Alfredo Chetta Clinica Pneumologica Università degli Studi di Parma Number of patients Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Lee JS, Nsa W, Hausmann LRM, et al. Quality of care for elderly patients hospitalized for pneumonia in the United States, 2006 to 2010. JAMA Intern Med. Published online September

More information

Respiratory Medicine. Some pet peeves and other random topics. Kyle Perrin

Respiratory Medicine. Some pet peeves and other random topics. Kyle Perrin Respiratory Medicine Some pet peeves and other random topics Kyle Perrin Overview 1. Acute asthma Severity assessment and management 2. Acute COPD NIV and other management 3. Respiratory problems in the

More information

Pneumonia in Older Adults: An Update

Pneumonia in Older Adults: An Update Pneumonia in Older Adults: An Update - 2010 Suzanne F. Bradley, M.D. Professor of Internal Medicine Geriatrics & Infectious Diseases University of Michigan Medical School GRECC - VA Ann Arbor HCS ID Hospitalizations

More information

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease 07 Contributor Dr David Tan Hsien Yung Definition, Diagnosis and Risk Factors for (COPD) Differential Diagnoses Goals of Management Management of COPD THERAPY AT EACH

More information

Prefe f rred d t e t rm: : rhi h no n s o inu n s u iti t s

Prefe f rred d t e t rm: : rhi h no n s o inu n s u iti t s HELP It s my sinuses! An overview of pharmacologic treatment of sinusitis Objectives Identify types of sinusitis and underlying pathology Examine common evidence based pharmacologic treatment for sinusitis

More information

Cases in employees. Cases. Day of onset (July)

Cases in employees. Cases. Day of onset (July) Cases in employees 70 60 50 Cases 40 30 20 10 0 0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 Day of onset (July) 70 60 50 40 Cases 30 Cases in employees and visitors Employees Visitors 20 10 0 0 2 4 6 8

More information

Quality Care Innovation lead clinician for integrated respiratory service georges ng* man kwong

Quality Care Innovation lead clinician for integrated respiratory service georges ng* man kwong Working in partnership Quality Care Innovation lead clinician for integrated respiratory service georges ng* man kwong chest physician pronounced ning qualified 1990 chief clinical information officer

More information

Antibiotics, Expectorants, and Cough Suppressants. Center For Cardiac Fitness Pulmonary Rehab The Miriam Hospital

Antibiotics, Expectorants, and Cough Suppressants. Center For Cardiac Fitness Pulmonary Rehab The Miriam Hospital Antibiotics, Expectorants, and Cough Suppressants Center For Cardiac Fitness Pulmonary Rehab The Miriam Hospital Objectives Review the mechanism of action (MOA), dosing, benefits, and various options for:

More information

Update in Pulmonology Update in Medicine and Primary Care November 11, 2017

Update in Pulmonology Update in Medicine and Primary Care November 11, 2017 Update in Pulmonology Update in Medicine and Primary Care November 11, 2017 Denitza P. Blagev, MD Pulmonary & Critical Care Medicine Director, Schmidt Chest Clinic Director, Lung Cancer Screening Program

More information

Bronchitis/Pneumonia Core Content Keith Conover, M.D., FACEP /15/02 Clinical Spectrum Chest pain, shoulder pain, neck pain, abdominal pain,

Bronchitis/Pneumonia Core Content Keith Conover, M.D., FACEP /15/02 Clinical Spectrum Chest pain, shoulder pain, neck pain, abdominal pain, Bronchitis/Pneumonia Core Content Keith Conover, M.D., FACEP 1.0 10/15/02 Clinical Spectrum Chest pain, shoulder pain, neck pain, abdominal pain, headache Links with smoking, pollen count, FH of asthma

More information

Upper...and Lower Respiratory Tract Infections

Upper...and Lower Respiratory Tract Infections Upper...and Lower Respiratory Tract Infections Robin Jump, MD, PhD Cleveland Geriatric Research Education and Clinical Center (GRECC) Louis Stokes Cleveland VA Medical Center Case Western Reserve University

More information

2012 Core Measures. Acute Myocardial Infarction (AMI)

2012 Core Measures. Acute Myocardial Infarction (AMI) 2012 Core Measures Acute Myocardial Infarction (AMI) Aspirin at Arrival Aspirin Prescribed at Discharge Angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) for left ventricular

More information

Corticosteroids in Severe CAP. Mervyn Mer Department of Medicine & ICU Johannesburg Hospital University of the Witwatersrand

Corticosteroids in Severe CAP. Mervyn Mer Department of Medicine & ICU Johannesburg Hospital University of the Witwatersrand Corticosteroids in Severe CAP Mervyn Mer Department of Medicine & ICU Johannesburg Hospital University of the Witwatersrand Introduction Much controversy and debate regarding the use of corticosteroids

More information

Chapter 22. Pulmonary Infections

Chapter 22. Pulmonary Infections Chapter 22 Pulmonary Infections Objectives State the incidence of pneumonia in the United States and its economic impact. Discuss the current classification scheme for pneumonia and be able to define hospital-acquired

More information

11/19/2012. The spectrum of pulmonary diseases in HIV-infected persons is broad.

11/19/2012. The spectrum of pulmonary diseases in HIV-infected persons is broad. The spectrum of pulmonary diseases in HIV-infected persons is broad. HIV-associated Opportunistic infections Neoplasms Miscellaneous conditions Non HIV-associated Antiretroviral therapy (ART)-associated

More information

HQO s Episode of Care for Chronic Obstructive Pulmonary Disease

HQO s Episode of Care for Chronic Obstructive Pulmonary Disease HQO s Episode of Care for Chronic Obstructive Pulmonary Disease Dr. Chaim Bell, MD PhD FRCPC Ontario Hospital Association Webcast October 23, 2013 Objectives 1. Describe the rationale and methodology for

More information

- Mycoplasma pneumoniae (MP): important respiratory pathogen in children that cause many upper and lower respiratory tract diseases, including

- Mycoplasma pneumoniae (MP): important respiratory pathogen in children that cause many upper and lower respiratory tract diseases, including KHOA DICH VU HO HAP - Mycoplasma pneumoniae (MP): important respiratory pathogen in children that cause many upper and lower respiratory tract diseases, including wheezing, coryza, bronchopneumonia. -

More information

Emerging respiratory infections: MERS and beyond. Victoria Johnston Hospital for Tropical Diseases

Emerging respiratory infections: MERS and beyond. Victoria Johnston Hospital for Tropical Diseases Emerging respiratory infections: MERS and beyond Victoria Johnston Hospital for Tropical Diseases victoria.johnston@lshtm.ac.uk Emerging infections What are emerging infections? New infection Known infection:

More information

Disclosures. Background. Definitions. Why Worry about these Infants? Goals. Bacterial infection in the neonate and young infant: a review

Disclosures. Background. Definitions. Why Worry about these Infants? Goals. Bacterial infection in the neonate and young infant: a review Disclosures Bacterial infection in the neonate and young infant: a review Russell J. McCulloh, MD Med-Peds Infectious Diseases August 8, 2017 I have no financial interests to disclose Funding: Eva and

More information

MANAGEMENT OF COMMUNITY ACQUIRED PNEUMONIA IN THE ASIA PACIFIC REGION

MANAGEMENT OF COMMUNITY ACQUIRED PNEUMONIA IN THE ASIA PACIFIC REGION MANAGEMENT OF COMMUNITY ACQUIRED PNEUMONIA IN THE ASIA PACIFIC REGION Chong-Kin LIAM Department of Medicine Faculty of Medicine University of Malaya Kuala Lumpur liamck@ummc.edu.my COMMUNITY ACQUIRED PNEUMONIA

More information

Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing

Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing National Institute for Health and Care Excellence Final Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing Evidence review December 2018 Contents Disclaimer The recommendations

More information

Diagnosis of Ventilator- Associated Pneumonia: Where are we now?

Diagnosis of Ventilator- Associated Pneumonia: Where are we now? Diagnosis of Ventilator- Associated Pneumonia: Where are we now? Gary French Guy s & St. Thomas Hospital & King s College, London BSAC Guideline 2008 Masterton R, Galloway A, French G, Street M, Armstrong

More information

Appropriate Antibiotic Prescribing. Frank Romanelli, Pharm.D., MPH, AAHIVP Professor & Associate Dean Paul F. Parker Endowed Professor of Pharmacy

Appropriate Antibiotic Prescribing. Frank Romanelli, Pharm.D., MPH, AAHIVP Professor & Associate Dean Paul F. Parker Endowed Professor of Pharmacy Appropriate Antibiotic Prescribing Frank Romanelli, Pharm.D., MPH, AAHIVP Professor & Associate Dean Paul F. Parker Endowed Professor of Pharmacy Objectives Discuss CDCs Core Elements of abx stewardship.

More information

AMI 100% 80% 60% 40% 20% AMI: Aspirin at Arrival Targets AMI: Aspirin at D/C 2 - Aspirin at Discharge: Targets 100% 80% 60% 40% 20%

AMI 100% 80% 60% 40% 20% AMI: Aspirin at Arrival Targets AMI: Aspirin at D/C 2 - Aspirin at Discharge: Targets 100% 80% 60% 40% 20% AMI AMI: 1 - Aspirin at Arrival AMI: 2 - Aspirin at Discharge AMI: Aspirin at Arrival Targets AMI: Aspirin at D/C 2 - Aspirin at Discharge: Targets AMI: 3 - ACEI or ARB for LVSD AMI: 4 - Adult Smoking

More information

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults SUPPLEMENT ARTICLE Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults Lionel A. Mandell, 1,a Richard G. Wunderink,

More information

Objectives. Pneumonia. Pneumonia. Epidemiology. Prevalence 1/7/2012. Community-Acquired Pneumonia in infants and children

Objectives. Pneumonia. Pneumonia. Epidemiology. Prevalence 1/7/2012. Community-Acquired Pneumonia in infants and children Objectives Community-Acquired in infants and children Review of Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America - 2011 Sabah Charania,

More information

Nosocomial Pneumonia. <5 Days: Non-Multidrug-Resistant Bacteria

Nosocomial Pneumonia. <5 Days: Non-Multidrug-Resistant Bacteria Nosocomial Pneumonia Meredith Deutscher, MD Troy Schaffernocker, MD Ohio State University Burden of Hospital-Acquired Pneumonia Second most common nosocomial infection in the U.S. 5-10 episodes per 1000

More information

Avian Influenza Clinical Picture, Risk profile & Treatment

Avian Influenza Clinical Picture, Risk profile & Treatment Avian Influenza Clinical Picture, Risk profile & Treatment Jantjie Taljaard Adult ID Unit Tygerberg Academic Hospital University of Stellenbosch jjt@sun.ac.za 083 419 1452 CLINICAL PICTURE The clinical

More information

Guess or get it right?

Guess or get it right? Guess or get it right? Antimicrobial prescribing in the 21 st century Robert Masterton Traditional Treatment Paradigm Conservative start with workhorse antibiotics Reserve more potent drugs for non-responders

More information

Wright, Respiratory Infections in the Challenging Patient. Disclosures. Objectives

Wright, Respiratory Infections in the Challenging Patient. Disclosures. Objectives Respiratory Infections in the Challenging Patient Wendy L. Wright, MS, APRN, BC, FAANP, FAAN Adult / Family Nurse Practitioner Owner - Wright & Associates Family Healthcare Amherst, New Hampshire Owner

More information

Pulmonary Exacerbations:

Pulmonary Exacerbations: Pulmonary Exacerbations: Better Understanding Needed Michael Tracy, MD Clinical Assistant Professor Pediatric Pulmonary CF Pulmonary Exacerbations Definition Importance Causes Treatment Research opportunities

More information

What is New in COPD: Times Are Changing! Meredith Chiasson, MD, FRCPC April 6, 2018

What is New in COPD: Times Are Changing! Meredith Chiasson, MD, FRCPC April 6, 2018 What is New in COPD: Times Are Changing! Meredith Chiasson, MD, FRCPC April 6, 2018 No disclosures Disclosures objectives How to diagnose & Assess severity Treatment: Pharmacologic Non-Pharmacologic Maintenance

More information

Charles Feldman. Charlotte Maxeke Johannesburg Academic Hospital University of the Witwatersrand

Charles Feldman. Charlotte Maxeke Johannesburg Academic Hospital University of the Witwatersrand Opportunistic Infections Community Acquired Pneumonia Charles Feldman Professor of Pulmonology and Chief Physician Charlotte Maxeke Johannesburg Academic Hospital University of the Witwatersrand Introduction

More information

Community-Acquired Bacterial Pneumonia: Is There Anything New? Steve Vacalis DO CaroMont Health Regional Medical Center Gastonia, North Carolina

Community-Acquired Bacterial Pneumonia: Is There Anything New? Steve Vacalis DO CaroMont Health Regional Medical Center Gastonia, North Carolina Community-Acquired Bacterial Pneumonia: Is There Anything New? Steve Vacalis DO CaroMont Health Regional Medical Center Gastonia, North Carolina This presentation is sponsored by: and supported by an educational

More information

Best of Pulmonary Jennifer R. Hucks, MD University of South Carolina School of Medicine

Best of Pulmonary Jennifer R. Hucks, MD University of South Carolina School of Medicine Best of Pulmonary 2012-2013 Jennifer R. Hucks, MD University of South Carolina School of Medicine Topics ARDS- Berlin Definition Prone Positioning For ARDS Lung Protective Ventilation In Patients Without

More information

A Comparative Study of Community-Acquired Pneumonia Patients Admitted to the Ward and the ICU*

A Comparative Study of Community-Acquired Pneumonia Patients Admitted to the Ward and the ICU* CHEST Original Research A Comparative Study of Community-Acquired Pneumonia Patients Admitted to the Ward and the ICU* Marcos I. Restrepo, MD, MSc, FCCP; Eric M. Mortensen, MD, MSc; Jose A. Velez, MD;

More information

2/4/2019. GOLD Objectives. GOLD 2019 Report: Chapters

2/4/2019. GOLD Objectives. GOLD 2019 Report: Chapters GOLD Objectives To provide a non biased review of the current evidence for the assessment, diagnosis and treatment of patients with COPD. To highlight short term and long term treatment objectives organized

More information

COPD. The goals of COPD. about. you quit. If you. efforts to quit. Heart

COPD. The goals of COPD. about. you quit. If you. efforts to quit. Heart How Is COPD Treated? COPD has no cure yet. However, lifestyle changes and treatments can help you feel better, stay more active, and slow the progress of the disease. The goals of COPD treatment include:

More information

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MOUSTAPHA ABIDALI, DO CRITICAL CARE FELLOW UNIVERSITY OF ARIZONA- PHOENIX

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MOUSTAPHA ABIDALI, DO CRITICAL CARE FELLOW UNIVERSITY OF ARIZONA- PHOENIX CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MOUSTAPHA ABIDALI, DO CRITICAL CARE FELLOW UNIVERSITY OF ARIZONA- PHOENIX COPD OUTLINE Definition and Overview Pathophysiology Diagnosis and Assessment Therapeutic

More information